Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation

    News

     
    11.03.2019

    Johannes Gojo erhält Förderung durch den Medizinisch Wissenschaftlichen Fonds des Bürgermeisters der Stadt Wien

     
    11.03.2019

    ACO ASSO vergibt Preis für beste wissenschaftliche Arbeit

     
    1.03.2019

    Fellinger Krebsforschung vergibt heuer 70.000 Euro an Forschungsförderung

     
    22.02.2019

    Thromboseentstehung bei Krebserkrankungen: CCC-Forschungsgruppe vorn im internationalen Spitzenfeld vertreten

     
    18.02.2019

    Florian Fitzal in das Brustkrebsguideline Panel der St Gallen Breast Cancer Conference gewählt

     
    1.02.2019

    KrebspatientInnen in Österreich profitieren frühzeitig von aktuellsten Therapien

     
    1.02.2019

    Wolfgang Mikulits erhält FWF Grant

     
    30.01.2019

    Individualisiert. Personalisiert. Zielgerichtet. - Behandlungsstrategien in der Krebstherapie 2019

     
    18.01.2019

    Metabolic Regulation of Liver Tumorigenesis

     
    11.01.2019

    Maria Sibilia ist interimistische Leiterin des CCC

     
    2.01.2019

    Das CCC dankt für das erfolgreiche Forschungsjahr 2018

     
    13.12.2018

    Metallhaltige Chemotherapien verstärken Wirkung der Immuntherapie bei Krebs

     
    13.12.2018

    Das CCC verabschiedet seinen Gründer Christoph Zielinski

     
    13.12.2018

    Krebsforschungslauf 2019 – Seien Sie dabei

     
    13.12.2018

    IKF-Cancer Lectures Series setzt neuen Schwerpunkt auf regionale Vernetzung

     
    12.12.2018

    Philipp Staber erhält Celgene Future Leader Award

     
    12.12.2018

    Rippenfellkrebs: Neuer Mechanismus der Ausbreitung entschlüsselt

     
    6.12.2018

    Neue Therapieoption reduziert Rückfallrisiko bei HER2-positivem Brustkrebs signifikant

     
    4.12.2018

    B-Zell-Lymphom: Neue Therapie-Option verdoppelt Lebensdauer im Vergleich zu Chemotherapie

     
    27.11.2018

    MALDI-Massenspektrometrie ermöglicht Differenzierung von Chemoresistenzen unterschiedlichen Grades in Krebszellen

     
    Treffer 121 bis 140 von 775
    << Erste < Vorherige Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Nächste > Letzte >>
     
Inhaltsbereich

CCC-Excellence Lecture: Paul A. Bunn

The next CCC-Excellence will be on lung Cancer. Paul A. Bunn will present the latest developments and findings in the fields of early detection, prevention and treatment of lung cancer. His talk’s title is: “Lung Cancer: early detection, prevention and treatment in 2018”
Wednesday, 23rd May 2018, 4 pm at CeMM, Seminar Room on level 8.


Paul A. Bunn, Jr. is Distinguished Professor and the James Dudley Chair in Cancer Research in the Division of Medical Oncology at the University of Colorado Cancer Center of the University of Colorado School of Medicine, where he has practiced and taught since 1984.

He received his B.A. from Amherst College in Amherst, Massachussets, and received his M.D. from Weill Cornell Medical College in New York City. He completed an internship and residency at the University of California San Francisco and a fellowship in medical oncology at the National Cancer Institute (Bethesda) Program. He is board certified in internal medicine and medical oncology. Paul Bunn served as the Head of the Division of Medical Oncology from 1984-1992 and as the Director of the University of Colorado Cancer Center from 1986-2009. In the IASLC, Bunn served on the Board of Directors from 1988 to 1994, as president from 1997-2000, and as CEO from 2004-2014. Dr. Bunn was the president of ASCO from 2002-2003.  
As an author of hundreds of articles, reviews and book chapters, his research is well known in the cancer world. He focuses primarily on novel therapies for lung cancer. Paul Bunn has led numerous national and local trials regarding the treatment of lung cancer, and his findings are credited with setting standards in the treatment of the disease.

Bunn has researched new personalized therapiesfor lung cancer thatcause fewer side effects than traditional, intravenous chemotherapy. He has also studied the genetics of the disease, seeking to learn how gene therapy could be used to combat the disease. He is currently the Principal Investigator on the Specialized Program in Research Excellence in Lung Cancer (SPORE) grant funded by the National Institutes of Health and theNational Cancer Institutethat aims to expand understanding about the biology of the disease, as well as to find new methods of diagnosis, prevention and treatment.

The event will be approved by the Austrian Medical Chamber with 1 DFP-Point.

CCC-Excellence Lecture

"Lung Cancer: early detection, prevention and treatment in 2018"

CeMM, Seminar Room, Level 8, Lazarettgasse 14, 1090 Vienna

Wednesday, 23 rd May 2018, 4 pm

<- Zurück zu: Comprehensive Cancer Center
 
 
Drucken
 
ccc_logo_en.gif
ccc_logo_en.gif
ccc_logo_en.gif

Schnellinfo

 
-- Initiative Krebsforschung / Krebsforschungslauf

-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Zuklappen
 
Ausklappen
 
 

Featured

 
 
 
 
 
 
 
 
 
 
 
 
 
21sextury.org fake hub hd sexy hub eroticax.org
© MedUni Wien |
 Impressum | Nutzungsbedingungen | Kontakt